Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ADVANTA LABS, LLC

NPI: 1801212766 · SOUTHLAKE, TX 76092 · Clinical Medical Laboratory · NPI assigned 03/14/2014

$39K
Total Medicaid Paid
6,281
Total Claims
2,976
Beneficiaries
27
Codes Billed
2018-01
First Month
2021-09
Last Month

Provider Details

Authorized OfficialHADIAN, YUSUF (AUTHORIZED OFFICIAL)
NPI Enumeration Date03/14/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 306 $0.00
2020 520 $0.00
2021 5,455 $39K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
81161 198 153 $14K
81404 1,673 297 $9K
81252 99 69 $5K
81401 278 198 $4K
81225 41 29 $3K
81407 399 266 $1K
81405 840 300 $833.30
81406 853 300 $782.22
81413 197 152 $646.95
81414 142 113 $646.95
81227 43 29 $148.91
81238 159 122 $0.00
81411 166 128 $0.00
81328 42 28 $0.00
81355 43 29 $0.00
81335 19 13 $0.00
81408 61 25 $0.00
81403 274 130 $0.00
81291 43 29 $0.00
81241 40 28 $0.00
81325 99 69 $0.00
81324 99 69 $0.00
81226 43 29 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 306 287 $0.00
81240 40 28 $0.00
81230 42 28 $0.00
81231 42 28 $0.00